Several possible studies
Story checked
AAP issues recommendations for pediatric RSV vaccination in 2026-2027 season (opens in a new tab)
medicalxpress.com · 2026-09-10
Short answer
Several possible studiesNo clear answer.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
AAP issues recommendations for pediatric RSV vaccination in 2026-2027 season
medicalxpress.com · 2026-09-10
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Several studies could be the source of this story.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Open claim evidenceSearch result
Several studies could fit.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Source layer
The 4 papers the story cites
Source study separated from background citations.
The research anchor for the report.
- The study this story reportsmentioned without context
Recommendations for the Prevention of Respiratory Syncytial Virus Disease in Infants and Children: Technical Report
Pediatrics · 2026
- The study this story reportsmentioned without context
Recommendations for COVID-19 Vaccines in Infants, Children, and Adolescents, 2026-2027: Policy Statement
Pediatrics · 2026
- The study this story reportsmentioned without context
Recommendations for COVID-19 Vaccines in Infants, Children, and Adolescents, 2026–2027: Technical Report
Pediatrics · 2026
- The study this story reportsmentioned without context
10.1542/peds.2026-079047/208784/recommendations-for-the-prevention-of-respiratory
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 6Not checkedThe AAP has issued recommendations for pediatric RSV vaccination in the 2026-2027 season, with new guidelines expanding the categories of high-risk children eligible for RSV vaccination and also addressing COVID-19 vaccines in policy statements and technical reports published in Pediatrics.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 6Not checkedThe AAP recommends RSV immunization for all infants younger than 8 months born during or entering their first RSV season unless there is documented protection from prenatal vaccination.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 6Not checkedRSV vaccination is recommended for children ages 8 through 19 months at high risk for severe RSV disease who are entering their second RSV season, including children born preterm, those with hemodynamically significant congenital heart disease, children with anatomic pulmonary abnormalities or neuromuscular disorders, and children with Down syndrome or other chromosomal differences.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 6Not checkedThe AAP recommends the 2026-2027 COVID-19 vaccine for all infants and children ages 6 through 23 months who do not have contraindications, and a single age-appropriate dose for children ages 2 through 18 at increased risk for severe COVID-19 regardless of prior vaccination status.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 5 of 6Not checkedAn AAP Committee on Infectious Diseases leader said the evidence is clear that these products work very well to prevent RSV and keep infants out of the hospital, and added that real-world impact is already being seen.View evidenceHide evidence
As statedvery well
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 6 of 6Not checkedThe article notes publication details for three Pediatrics papers: an RSV technical report and two COVID-19 papers (a policy statement and a technical report), all from 2026.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
Crossref, PubMed, Europe PMC · 18 candidate papers
Recommendations for the Prevention of Respiratory Syncytial Virus Disease in Infants and Children: Technical Report
Pediatrics · 2026 · Crossref
Recommendations for COVID-19 Vaccines in Infants, Children, and Adolescents, 2026-2027: Policy Statement
Pediatrics · 2026 · Crossref
Recommendations for COVID-19 Vaccines in Infants, Children, and Adolescents, 2026–2027: Technical Report
Pediatrics · 2026 · Crossref
Association between nirsevimab coverage and pediatric emergency department visits for bronchiolitis in 12 European countries: An interrupted time-series analysis.
PLoS Medicine · 2026 · PubMed
Reduction of Respiratory Syncytial Virus Hospitalization Among Premature Infants and Infants With Bronchopulmonary Dysplasia Using Respiratory Syncytial Virus Immune Globulin Prophylaxis
Pediatrics · 1997 · Crossref
And 13 more candidates considered.